SALVAGE REGIMENT WITH FLAT FOR REFRACTORY AND RELAPSED AML: EXPERIENCE A SINGLE CENTRE

被引:0
|
作者
Salamanca, A. [1 ]
Madrigal, D. [1 ]
Saldana, R. [1 ]
Martin, E. [1 ]
Garzon, S. [1 ]
机构
[1] Hosp Jerez de la Frontera, Area Sanitaria Norte Cadiz, Haematol, Cadiz, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1667
引用
收藏
页码:681 / 681
页数:1
相关论文
共 50 条
  • [21] Real World Practice of FLAGIdarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience
    Lee, Brian
    Blackmon, Amanda
    Ngo, Dat
    Chen, Jason
    Shan, Haoyue
    Desai, Amrita
    Artz, Andy
    Aldoss, Ibrahim
    Al Malki, Monzr
    Salhotra, Amandeep
    Ball, Brian
    Koller, Paul
    Pullarkat, Vinod
    Nakamura, Ryotaro
    Stein, Anthony
    Marcucci, Guido
    Sandhu, Karamjeet
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S256 - S257
  • [22] FLAMSA-RIC for haematopoietic cell transplantation can overcome the poor prognosis of primary refractory or relapsed AML: a single-centre experience
    Federmann, B.
    Schneidawind, D.
    Faul, C.
    Vogel, W.
    Kanz, L.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S412 - S413
  • [23] The efficacy and safety of BV-ICE salvage therapy for relapsed/refractory Hodgkin lymphoma. A single centre
    El Cheikh, Jean
    Amhaz, Ghid
    Zahreddine, Ammar
    Abou Dalle, Iman
    Bazarbachi, Ali
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2022, 70 (03)
  • [24] Clofarabine-Based Salvage Therapy and Conditioning Regimen in Patients with Relapsed or Refractory AML
    Middeke, Jan Moritz
    Parmentier, Stefani
    Alakel, Nael
    Schaich, Markus
    Thiede, Christian
    Platzbecker, Uwe
    Roellig, Christoph
    Haenel, Mathias
    Stuhler, Gernot
    Morgner, Anke
    Eulenstein, Ute
    Ehninger, Gerhard
    Bornhauser, Martin
    Schetelig, Johannes
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S227 - S227
  • [25] TREATMENT OF RELAPSED/REFRACTORY LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTRE EXPERIENCE FROM DEVELOPING WORLD
    Dua, Vikas
    Yadav, Satya Prakash
    Ramzan, Mohammed
    Sachdeva, Anupam
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1045 - 1046
  • [26] Factors affecting outcome of salvage chemotherapy with FLAG +/- idarubicin for adults with relapsed/refractory AML
    Boden, A.
    Byrne, J.
    Das Gupta, E.
    Russell, N.
    Baddeley, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 63 - 64
  • [27] SALVAGE TREATMENT WITH SINGLE-AGENT BENDAMUSTINE FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: AN ITALIAN MONOCENTRIC EXPERIENCE
    Ricciuti, G.
    Finolezzi, E.
    Falorio, S.
    Luciani, S.
    Ranucci, E.
    Angrilli, F.
    HAEMATOLOGICA, 2014, 99 : 677 - 678
  • [28] Donor lymphocyte infusion (DLI) as salvage treatment for refractory or relapsed lymphoid malignancies after allogeneic stem cell transplantation: Experience from a single centre
    Martin Sanchez, G.
    Insunza, A.
    Yanez, L.
    Bermudez, A.
    Colorado, M.
    Lopez Duarte, M.
    Amunarriz, C.
    Iratil, O.
    Lopez Pereira, B.
    Richard, C.
    Arroyo, J. L.
    Conde, E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S122 - S123
  • [29] APSCT for relapsed or refractory HD and NHL - analysis of prognostic factors in single centre experience.
    Holowiecki, J
    Wojnar, J
    Krawczyk-Kulis, M
    Wojciechowska, M
    Kachel, L
    Markiewicz, M
    Kata, D
    BONE MARROW TRANSPLANTATION, 1998, 21 : S167 - S167
  • [30] Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience
    Hafez, Rania
    Hussein, Safinaz
    Ismail, Marwa
    ALEXANDRIA JOURNAL OF MEDICINE, 2018, 54 (04) : 679 - 683